181 related articles for article (PubMed ID: 12379674)
1. Role of Vibrio cholerae O139 surface polysaccharides in intestinal colonization.
Nesper J; Schild S; Lauriano CM; Kraiss A; Klose KE; Reidl J
Infect Immun; 2002 Nov; 70(11):5990-6. PubMed ID: 12379674
[TBL] [Abstract][Full Text] [Related]
2. The Vibrio cholerae O139 serogroup antigen includes an O-antigen capsule and lipopolysaccharide virulence determinants.
Waldor MK; Colwell R; Mekalanos JJ
Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11388-92. PubMed ID: 7972070
[TBL] [Abstract][Full Text] [Related]
3. Vibrio cholerae O139 Bengal possesses a capsular polysaccharide which may confer increased virulence.
Weintraub A; Widmalm G; Jansson PE; Jansson M; Hultenby K; Albert MJ
Microb Pathog; 1994 Mar; 16(3):235-41. PubMed ID: 8090081
[TBL] [Abstract][Full Text] [Related]
4. Vibrio cholerae O139 capsular polysaccharide confers complement resistance in the absence or presence of antibody yet presents a productive target for cell lysis: implications for detection of bactericidal antibodies.
Attridge SR; Holmgren J
Microb Pathog; 2009 Dec; 47(6):314-20. PubMed ID: 19818394
[TBL] [Abstract][Full Text] [Related]
5. Characterizing lipopolysaccharide and core lipid A mutant O1 and O139 Vibrio cholerae strains for adherence properties on mucus-producing cell line HT29-Rev MTX and virulence in mice.
Schild S; Lamprecht AK; Fourestier C; Lauriano CM; Klose KE; Reidl J
Int J Med Microbiol; 2005 Aug; 295(4):243-51. PubMed ID: 16128399
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Vibrio cholerae O1 El tor galU and galE mutants: influence on lipopolysaccharide structure, colonization, and biofilm formation.
Nesper J; Lauriano CM; Klose KE; Kapfhammer D; Kraiss A; Reidl J
Infect Immun; 2001 Jan; 69(1):435-45. PubMed ID: 11119535
[TBL] [Abstract][Full Text] [Related]
7. Construction and characterization of a potential live oral carrier-based vaccine against Vibrio cholerae O139.
Favre D; Cryz SJ; Viret JF
Infect Immun; 1996 Sep; 64(9):3565-70. PubMed ID: 8751900
[TBL] [Abstract][Full Text] [Related]
8. Structural studies on the short-chain lipopolysaccharide of Vibrio cholerae O139 Bengal.
Knirel YA; Widmalm G; Senchenkova SN; Jansson PE; Weintraub A
Eur J Biochem; 1997 Jul; 247(1):402-10. PubMed ID: 9249053
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to the truncated (short) form of 'O' polysaccharides (TFOP) of Vibrio cholerae O139 lipopolysaccharides protect mice against experimental cholera induced by encapsulated O139 strains and such protection is mediated by inhibition of intestinal colonization of vibrios.
Nandy RK; Mukhopadhyay S; Ghosh AN; Ghose AC
Vaccine; 1999 Jul; 17(22):2844-52. PubMed ID: 10438055
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of virstatin resistance by non-O1/non-O139 strains of Vibrio cholerae.
Shakhnovich EA; Sturtevant D; Mekalanos JJ
Mol Microbiol; 2007 Dec; 66(6):1331-41. PubMed ID: 17986190
[TBL] [Abstract][Full Text] [Related]
11. Vibrio cholerae O139 requires neither capsule nor LPS O side chain to grow inside Acanthamoeba castellanii.
Abd H; Saeed A; Weintraub A; Sandström G
J Med Microbiol; 2009 Jan; 58(Pt 1):125-131. PubMed ID: 19074664
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of the properties of Vibrio cholerae O139, O1 and other non-O1 strains.
Nandy RK; Sengupta TK; Mukhopadhyay S; Ghose AC
J Med Microbiol; 1995 Apr; 42(4):251-7. PubMed ID: 7707332
[TBL] [Abstract][Full Text] [Related]
13. Differential immunogenicity of Vibrio cholerae O139 variants expressing different combinations of naturally occurring and atypical forms of the serogroup polysaccharide.
Attridge SR; Wallerström G; Li BL; Morona R; Holmgren J
Vaccine; 2009 Feb; 27(7):1055-61. PubMed ID: 19100303
[TBL] [Abstract][Full Text] [Related]
14. The capsule polysaccharide structure and biogenesis for non-O1 Vibrio cholerae NRT36S: genes are embedded in the LPS region.
Chen Y; Bystricky P; Adeyeye J; Panigrahi P; Ali A; Johnson JA; Bush CA; Morris JG; Stine OC
BMC Microbiol; 2007 Mar; 7():20. PubMed ID: 17362509
[TBL] [Abstract][Full Text] [Related]
15. Cloning and sequence of a region encoding a surface polysaccharide of Vibrio cholerae O139 and characterization of the insertion site in the chromosome of Vibrio cholerae O1.
Comstock LE; Johnson JA; Michalski JM; Morris JG; Kaper JB
Mol Microbiol; 1996 Feb; 19(4):815-26. PubMed ID: 8820651
[TBL] [Abstract][Full Text] [Related]
16. TcpA pilin sequences and colonization requirements for O1 and O139 vibrio cholerae.
Rhine JA; Taylor RK
Mol Microbiol; 1994 Sep; 13(6):1013-20. PubMed ID: 7854116
[TBL] [Abstract][Full Text] [Related]
17. Evolutionary and functional analyses of variants of the toxin-coregulated pilus protein TcpA from toxigenic Vibrio cholerae non-O1/non-O139 serogroup isolates.
Boyd EF; Waldor MK
Microbiology (Reading); 2002 Jun; 148(Pt 6):1655-1666. PubMed ID: 12055286
[TBL] [Abstract][Full Text] [Related]
18. Characterization and Genetic Variation of Vibrio cholerae Isolated from Clinical and Environmental Sources in Thailand.
Siriphap A; Leekitcharoenphon P; Kaas RS; Theethakaew C; Aarestrup FM; Sutheinkul O; Hendriksen RS
PLoS One; 2017; 12(1):e0169324. PubMed ID: 28103259
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharides of Vibrio cholerae. I. Physical and chemical characterization.
Chatterjee SN; Chaudhuri K
Biochim Biophys Acta; 2003 Oct; 1639(2):65-79. PubMed ID: 14559113
[TBL] [Abstract][Full Text] [Related]
20. The capsule and O antigen in Vibrio cholerae O139 Bengal are associated with a genetic region not present in Vibrio cholerae O1.
Comstock LE; Maneval D; Panigrahi P; Joseph A; Levine MM; Kaper JB; Morris JG; Johnson JA
Infect Immun; 1995 Jan; 63(1):317-23. PubMed ID: 7528734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
